Essilor

Essilor ranked one of the World’s Most Innovative Companies by Forbes magazine for 5th consecutive year

For the 5th year in a row, Essilor has been listed to Forbes magazine’s world’s top 100 most innovative companies. This recognition underlines Essilor’s strategy of putting innovation at the heart of its growth ambition.
A pioneer in ophthalmic optics

In more than 165 years, Essilor’s scope of innovation has grown considerably without compromising its original core business of ophthalmic optics. Credited with breakthroughs that have left their mark on the world of optics such as progressive, organic and photochromic organic lenses, the Essilor Group is a pioneer when it comes to delivering its mission of improving lives by improving sight.

“Innovation is part of our DNA and a key driver in our business of providing solutions to a fundamental human need: good vision. Being close to customers and eye care professionals all around the world allows us to identify vision needs, anticipate vision solutions and thus better answer the correction, protection and prevention needs of every individual. Our teams’ commitment in improving technologies and access to quality vision care is central to our mission, our growth and to the industry’s evolution, in the benefit of eye health.” said Jean Carrier, Chief Operating Officer of Essilor International who oversees the Group’s innovation related activities.

A global organization driving performance
One of the keys to Essilor’s innovation is the Group’s close-knit network of resources and expertise. Essilor has 5 Research & Development centers amongst which 3 Centers for Innovation and Technologies (CI&T), uniting Research, Engineering and Marketing teams in Créteil (close to Paris, France), Dallas (USA) and Singapore. The Group also operates a photochromic technology center (Transitions) in Pinnelas Park (USA) and a joint research center with Nikon (NEIJRC) in Japan. Another driver of innovation is the wide network of research and collaborative partnerships with around 100 agreements signed with universities, public and private sector laboratories and industrial companies. The Group invests 180 M€ in research and innovation, holds 7 200 patents and 40% of its revenue is generated by products less than 4 years old.

N.B. – The text does not bind the staff of LMFInternational. Only the companies, organizations and associations which sign the press release and which are clearly indicated in the title of the text, are responsible for its information and